Other studies have demonstrated that Cd47 deficiency or CD47-Fc protein treatment limits several inflammatory diseases including colitis,70 bacterial induced arthritis,71 experimental autoimmune encephalitis,72 experimental autoimmune uveitis,73 SLE,74 and bacterial pneumonia.62 This evidence concerns the gene CD47 and bacterial pneumonia.